Bird & Bird advised Nexstim on cooperation and investment agreements with Brainlab

International law firm Bird & Bird has successfully advised Nexstim Plc, a Finnish, globally operating growth-oriented medical technology company, on its cooperation agreement and investment agreement with Brainlab AG, a leading German developer of advanced medical technology solutions.

The cooperation agreement aims at the advancement of non-invasive brain mapping technologies, as well as the distribution of certain Nexstim products by Brainlab in the segment. 

In connection with the cooperation agreement, Brainlab and Nexstim have also agreed on a maximum of EUR 5,095,000 equity investment into Nexstim by Brainlab. 

Bird & Bird’s advisory team, consisting of partners Maria Carlsson, Laura Huomo, and Iina-Mari Supperi, along with Counsel Vuokko Rajamäki and associates Juliana Kliesch, Marla Melin and Rondy Stenman, provided comprehensive legal support for both the cooperation and investment agreements.

News & Deals

More News & Deals

News

Bird & Bird China wins CBLJ "Deals of the Year 2024"

Apr 17 2025

Read More

Deal

Bird & Bird advises De La Rue plc on public takeover

Apr 17 2025

Read More

News

Bird & Bird and OXYGY announce together with the European Commission the use cases selected for third cohort of European Blockchain Sandbox

Apr 15 2025

Read More

News

Bird & Bird flies high with most wins at European Managing IP (MIP) Awards

Apr 11 2025

Read More

Deal

Bird & Bird advises Milestone on the acquisition of Brighter AI

Apr 09 2025

Read More

News

Bird & Bird advises on the sale of a controlling interest in international creative agency, Amplify, to Common Interest

Apr 08 2025

Read More